In The Media
Stephen Sheller appeared on The American Law Journal to discuss why, with historic False Claims Settlements in the billions, are CEOs not going to jail nor are corporations pleading to felony charges? Hosted
Stephen Sheller appeared on the Philadelphia CNN-News affiliate WFMZ-TV program The American Law Journal on “How Is Pharma Faring in the Courts?” Host Christopher Naughton welcomed plaintiff’s attorneys Christopher Placitella, Esq. of Cohen Placitella & Roth, Stephen Sheller
J&J to pay $2.2B for Improper Promotion of Risperdal BY DAVID SELL WASHINGTON – Health-care giant Johnson & Johnson agreed Monday to plead guilty to a criminal misdemeanor charge and pay $2.2 billion
The Legal Intelligencer 2014-01-15 Individual suit filings related to the antipsychotic drug Risperdal have been increasing in the Philadelphia Court of Common Pleas, First Judicial District leaders say. The uptick has been steady
The Toronto Star 2014-06-26 By: David Bruser News Reporter, Jesse McLean Investigative News reporter, Andrew Bailey Data Analyst, Published on Thu Jun 26 2014 A 15-year-old girl who wanted to clear her acne was prescribed the antibiotic minocycline. The teen
Law.com 2014-03-04 Several products liability attorneys say that the recent appearance of lawsuits nationwide against the manufacturers of testosterone therapy drugs indicates the potential for multidistrict litigation and possibly a new mass tort.